1. Home
  2. HUBC vs PHGE Comparison

HUBC vs PHGE Comparison

Compare HUBC & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • PHGE
  • Stock Information
  • Founded
  • HUBC 2017
  • PHGE 2015
  • Country
  • HUBC Israel
  • PHGE Israel
  • Employees
  • HUBC N/A
  • PHGE N/A
  • Industry
  • HUBC
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBC
  • PHGE Health Care
  • Exchange
  • HUBC Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • HUBC 15.2M
  • PHGE 13.3M
  • IPO Year
  • HUBC N/A
  • PHGE N/A
  • Fundamental
  • Price
  • HUBC $0.81
  • PHGE $0.77
  • Analyst Decision
  • HUBC
  • PHGE Strong Buy
  • Analyst Count
  • HUBC 0
  • PHGE 2
  • Target Price
  • HUBC N/A
  • PHGE $13.50
  • AVG Volume (30 Days)
  • HUBC 3.8M
  • PHGE 110.1K
  • Earning Date
  • HUBC 12-13-2024
  • PHGE 11-14-2024
  • Dividend Yield
  • HUBC N/A
  • PHGE N/A
  • EPS Growth
  • HUBC N/A
  • PHGE N/A
  • EPS
  • HUBC N/A
  • PHGE N/A
  • Revenue
  • HUBC $33,357,000.00
  • PHGE N/A
  • Revenue This Year
  • HUBC N/A
  • PHGE N/A
  • Revenue Next Year
  • HUBC N/A
  • PHGE N/A
  • P/E Ratio
  • HUBC N/A
  • PHGE N/A
  • Revenue Growth
  • HUBC N/A
  • PHGE N/A
  • 52 Week Low
  • HUBC $0.37
  • PHGE $0.48
  • 52 Week High
  • HUBC $2.17
  • PHGE $8.55
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 58.71
  • PHGE 56.75
  • Support Level
  • HUBC $0.51
  • PHGE $0.70
  • Resistance Level
  • HUBC $0.92
  • PHGE $0.80
  • Average True Range (ATR)
  • HUBC 0.20
  • PHGE 0.08
  • MACD
  • HUBC 0.00
  • PHGE 0.01
  • Stochastic Oscillator
  • HUBC 44.09
  • PHGE 60.76

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

Share on Social Networks: